LATE-BREAKING ABSTRACT: GLCCI1 rs37972 gene‘s polymorphism correlation with response to oral glucocorticosteroids treatment in severe asthmatics from the BIOAIR cohort

M. Kupczyk, L. Reinius, R. Middelvleld, B. Dahlen, J. Kere, S. E. Dahlen (Stockholm, Sweden)

Source: Annual Congress 2012 - Gene-environment treatment and asthma
Session: Gene-environment treatment and asthma
Session type: Poster Discussion
Number: 469
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Kupczyk, L. Reinius, R. Middelvleld, B. Dahlen, J. Kere, S. E. Dahlen (Stockholm, Sweden). LATE-BREAKING ABSTRACT: GLCCI1 rs37972 gene‘s polymorphism correlation with response to oral glucocorticosteroids treatment in severe asthmatics from the BIOAIR cohort. Eur Respir J 2012; 40: Suppl. 56, 469

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
ADRB2 haplotypes and risk of exacerbations in asthmatic children and young adults treated with long-acting ß2-agonists: A meta-analysis in the PiCA consortium
Source: International Congress 2019 – Genes and environment
Year: 2019

Genome-wide association study of inhaled corticosteroid response in African-admixed children with asthma.
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017


Genome-wide association study of asthma exacerbations in European children treated with inhaled corticosteroids
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017


Effects of Arg16Gly polymorphism in ADRB2 gene on responses to salmeterol or montelukast added to inhaled corticosteroids in Japanese asthmatic subjects
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012

LATE-BREAKING ABSTRACT: A dose-ranging study of dupilumab in patients (pts) with uncontrolled asthma despite use of inhaled corticosteroids plus a long-acting beta-agonist (ICS/LABA): Final data
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015


The associations of polymorphism C3435T multidrug resistance gene (MDR1) and regimen of inhaled glucocorticosteroid therapy in bronchial asthma (BA) patients
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008

Association between the GLCCI1 variant and response to inhaled corticosteroids in South Vietnamese asthmatics
Source: International Congress 2018 – Variant forms of asthma
Year: 2018



LATE-BREAKING ABSTRACT: Indacaterol/glycopyrronium (IND/GLY) reduces the risk of exacerbations versus salmeterol/fluticasone (SFC) in moderate-to-very severe COPD patients irrespective of prior ICS/LABA/LAMA therapy: The FLAME study
Source: International Congress 2016 – Novel strategies on COPD and asthma management
Year: 2016

Genome-wide association study of asthma symptoms despite inhaled corticosteroids use in Dutch children.
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017

Plasma protein profiles as markers of asthma severity and exposure to oral corticosteroids in U-BIOPRED and BIOAIR
Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma
Year: 2020




Meta-analysis of inhaled corticosteroids response in children with asthma.
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019


LATE-BREAKING ABSTRACT: Association of airway bacterial load with inhaled corticosteroid dosage in stable COPD
Source: Annual Congress 2012 - New insights in pneumology - ERS inter-Assemblies late-breaking abstracts
Year: 2012

Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004

LATE-BREAKING ABSTRACT: Which predictors in COPD patients with the frequent exacerbator phenotype predict the treatment response to maintenance therapy with azithromycin?
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016


E-cadherin (CDH-1) polymorphisms associate with airway remodeling, inflammation and FEV1 decline in asthma patients using inhaled corticosteroids (ICS)
Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases
Year: 2010

Evaluation of the association between eosinophil variability and effects of inhaled corticosteroids in COPD patients using propensity score matching
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019


Induced sputum in children with mild-moderate persistent asthma: the effect of inhaled corticosteroid treatment
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008

Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids
Source: Eur Respir J 2001; 18: Suppl. 33, 531s
Year: 2001

Association between genetic polymorphisms of the β2-AR and response to salbutamol in patients with atopic bronchial asthma of Kyrgyz nationality
Source: Eur Respir J 2006; 28: Suppl. 50, 236s
Year: 2006

Assessment of asthma control in asthmatic patients Brazilian carriers of the Arg16Gly polymorphism of the β2 adrenorreceptor gene
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009